HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sonia Fargue Selected Research

Pyridoxal Phosphate (Pyridoxal 5 Phosphate)

1/2016Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay.
10/2015Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I.
10/2013Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sonia Fargue Research Topics

Disease

14Primary hyperoxaluria type 1
05/2022 - 08/2006
13Primary Hyperoxaluria (Oxaluria, Primary)
01/2021 - 08/2006
11Kidney Calculi (Kidney Stone)
05/2022 - 01/2013
9Hyperoxaluria (Oxaluria)
05/2022 - 08/2006
6Chronic Kidney Failure (Chronic Renal Failure)
05/2022 - 08/2006
5Renal Insufficiency (Renal Failure)
01/2020 - 03/2010
3Nephrocalcinosis
01/2020 - 03/2010
3Chronic Renal Insufficiency
01/2020 - 06/2010
3Urolithiasis
05/2012 - 08/2006
1Diarrhea
05/2010
1Segmental glomerulosclerosis
11/2009
1Lipoprotein Glomerulopathy
11/2009
1Glomerulonephritis
11/2009
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2009
1Neoplasms (Cancer)
11/2009
1Hereditary Nephritis (Alport Syndrome)
11/2009
1Nephrotic Syndrome (Syndrome, Nephrotic)
11/2009
1Proteinuria
11/2009
1Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
11/2009
1Membranous Glomerulonephritis (Membranous Nephropathy)
11/2009
1Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome)
11/2009
1Kidney Diseases (Kidney Disease)
12/2008
1Hyperuricemia
12/2008
1Shock
08/2006

Drug/Important Bio-Agent (IBA)

15OxalatesIBA
05/2022 - 08/2006
10Calcium OxalateIBA
05/2022 - 06/2010
9EnzymesIBA
01/2016 - 08/2006
8Alanine-glyoxylate transaminase (alanine-glyoxylate aminotransferase)IBA
01/2016 - 08/2006
5glyoxylic acid (glyoxylate)IBA
01/2020 - 01/2011
3Alanine (L-Alanine)FDA Link
01/2021 - 07/2011
3Hydroxyproline (4 Hydroxyproline)IBA
01/2020 - 01/2016
3Pyridoxal Phosphate (Pyridoxal 5 Phosphate)IBA
01/2016 - 10/2013
3Pyridoxine (Pyridoxin)FDA LinkGeneric
10/2015 - 07/2011
2Oxidoreductases (Dehydrogenase)IBA
01/2020 - 01/2016
2Biomarkers (Surrogate Marker)IBA
01/2020 - 06/2010
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2019 - 10/2014
2glycollate oxidaseIBA
09/2016 - 01/2016
1SaltsIBA
05/2022
1CalciumIBA
05/2022
1glycolic acid (glycolate)IBA
01/2020
1Small Interfering RNA (siRNA)IBA
01/2016
1PyridoxalIBA
10/2015
1PyridoxamineIBA
10/2015
1Vitamin B 6IBA
10/2015
1Amino AcidsFDA Link
01/2013
1MineralsIBA
06/2010
1Tacrolimus (Prograf)FDA LinkGeneric
05/2010
1DNA (Deoxyribonucleic Acid)IBA
03/2010
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2009
1AntibodiesIBA
11/2009
1Immunoglobulins (Immunoglobulin)IBA
11/2009
1Uric Acid (Urate)IBA
12/2008

Therapy/Procedure

5Kidney Transplantation
05/2012 - 08/2006
4Liver Transplantation
01/2020 - 08/2006
4Therapeutics
01/2020 - 08/2006
3Transplantation
07/2011 - 12/2008
2Organ Transplantation
01/2015 - 10/2010
1RNAi Therapeutics
01/2016
1Conservative Treatment
10/2009
1Lithotripsy (Extracorporeal Shockwave Lithotripsy)
08/2006
1Stents
08/2006